# Validation of Oxygen Nanosensor in Mitochondrial Myopathy

> **NCT04086329** · PHASE1 · RECRUITING · sponsor: **Children's Hospital of Philadelphia** · enrollment: 24 (estimated)

## Conditions studied

- Mitochondrial Myopathies
- Mitochondrial Diseases

## Interventions

- **DEVICE:** Nanosensor

## Key facts

- **NCT ID:** NCT04086329
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-17
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086329, "Validation of Oxygen Nanosensor in Mitochondrial Myopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04086329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*